fMRI: Use in early Alzheimer's disease and in clinical trials

Future Neurology

Volumn 3, Issue 4, 2008, Pages 409-421

  Pihlajamäki, Maija ^a,b   Sperling, Reisa A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Aging; Alzheimer's disease; Clinical trials; Functional MRI; Medial temporal lobe; Memory; Mild cognitive impairment; Posteromedial cortex; Task related activation; Testing state

Indexed keywords

APOLIPOPROTEIN E; CHOLINESTERASE INHIBITOR; DONEPEZIL; FLUORODEOXYGLUCOSE F 18; GALANTAMINE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PLACEBO; RIVASTIGMINE;

ALZHEIMER DISEASE; AUTOPSY; BRAIN CORTEX; BRAIN DAMAGE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; FUNCTIONAL ASSESSMENT; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE MUTATION; GENETIC RISK; HETEROZYGOTE; HIPPOCAMPAL SCLEROSIS; HUMAN; LONG TERM MEMORY; MEMORY CONSOLIDATION; MEMORY DISORDER; MENTAL CAPACITY; MENTAL TASK; MENTAL TEST; MINI MENTAL STATE EXAMINATION; NERVE POTENTIAL; NEUROFIBRILLARY TANGLE; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN BLOOD LEVEL; PATHOPHYSIOLOGY; PERFUSION WEIGHTED IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYMPTOM; TASK PERFORMANCE; TEMPORAL LOBE; TEST RETEST RELIABILITY; VISUAL MEMORY; WORD LIST RECALL;

EID: 47249085131     PISSN: 14796708     EISSN: None     Source Type: Journal    
DOI: 10.2217/14796708.3.4.409     Document Type: Review

References (117)

1. Maurer K, Volk S, Gerbaldo H: Auguste D and Alzheimer's disease. Lancet 349, 1546-1549 (1997).
2. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE: Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nature Genet. 39, 17-23 (2007).
3. Jellinger KA: Alzheimer disease and cerebrovascular pathology: an update. J. Neural Transm. 109, 813-836 (2002).
4. Henry-Feugeas MC: MRI of the 'Alzheimer syndrome'. J. Neuroradiol. 34, 220-227 (2007).
5. Jagust WJ, Zheng L, Harvey DJ et al.: Neuropathological basis of magnetic resonance images in aging and dementia. Ann. Neurol. 63, 72-80 (2008).
6. Kaduszkiewicz H, Zimmermann T, Beck-Bornholdt HP, van den Bussche H: Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials. BMJ 331, 321-327 (2005).
7. Tanzi RE, Bertram L: New frontiers in Alzheimer's disease genetics. Neuron 32, 181-184 (2001).
8. Saunders AM, Strittmatter WJ, Schmechel D et al.: Association of apolipoprotein E affele ε4 with late-onset family and sporadic Alzheimer's disease. Neurology 43, 1467-1472 (1993).
9. Braak H, Braak E: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berl.) 82, 239-259 (1991).
10. Kwong KK, Belliveau JW, Chesler DA et al.: Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc. Natl Acad. Sci. USA 89, 5675-5679 (1992).
11. Stern CE, Corkin S, Gonzalez RG et al.: The hippocampal formation participates in novel picture encoding: evidence from functional magnetic resonance imaging. Proc. Natl Acad. Sci. USA 93, 8660-8665 (1996).
12. Gabrieli JDE, Brewer JB, Desmond JE, Glover GH: Separate neural bases of two fundamental memory processes in the human medial temporal lobe. Science 276, 264-266 (1997).
13. Brewer JB, Zhao Z, Desmond JE, Glover GH, Gabrieli JD: Making memories: brain activity that predicts how well visual experience will be remembered. Science 281, 1185-1187 (1998).
14. Wagner AD, Schacter DL, Rotte M et al.: Building memories: remembering and forgetting of verbal experiences as predicted by brain activity. Science 281, 1188-1191 (1998).
15. Sperling RA, Bates JF, Cocchiarella AJ et al.: Encoding novel face-name associations: a functional MRI study. Hum. Brain Mapp. 14, 129-139 (2001).
16. Pihlajamäki M, Tanila H, Hänninen T et al.: Encoding of novel picture pairs activates the perirhinal cortex: an fMRI study. Hippocampus 13, 67-80 (2003).
17. Scoville WB, Milner B: Loss of recent memory after bilateral hippocampal lesions. J. Neurol. Neurosurg. Psychiatry 20, 11-21 (1957).
18. Eichenbaum H: A cortical-hippocampal system for declarative memory. Nat. Rev. Neurosci. 1, 41-50 (2000).
19. Raichle ME, Mintun MA: Brain work and brain imaging. Annu. Rev. Neurosci. 29, 449-476 (2006).
20. Buckner RL, Andrews-Hanna JR, Schacter DL: The brain's default mode network: anatomy, function, and relevance to disease. Ann. NY Acad. Sci. 1124, 1-38 (2008).
21. Rombouts SA, Barkhof F, Veltman DJ et al.: Functional MR imaging in Alzheimer's disease during memory encoding. Am. J. Neuroradiol. 21, 1869-1875 (2000).
22. Sperling RA, Bates JF, Chua EF et al.: fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease. J. Neurol Neurosurg. Psychiatry 74, 44-50 (2003).
23. Pariente J, Cole S, Henson R et al.: Alzheimer's patients engage an alternative network during a memory task. Ann. Neurol. 58, 870-879 (2005).
24. Klunk WE, Engler H, Nordberg A et al.: Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol. 55, 306-319 (2004).
25. Nelissen N, Vandenbulcke M, Fannes K et al.: AP amyloid deposition in the language system and how the brain responds. Brain 130, 2055-2069 (2007).
26. Hyman BT, Van Hoesen GW Damasio AR, Barnes CL: Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 225, 1168-1170 (1984).
27. Gomez Isla T, Hollister R. West H et al.: Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann. Neurol. 41, 17-24 (1997).
28. Kordower JH, Chu Y, Stebbins GT et al.: Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann. Neurol. 49, 202-213 (2001).
29. Scheff SW, Price DA, Schmitt FA, Mufson EJ: Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol. Aging 27, 1372-1384 (2006).
30. Small SA, Perera GM, DeLaPa R, Mayeux R, Stern Y: Differential regional dysfunction of die hippocampal formation among elderly with memory decline and Alzheimer's disese. Ann. Neurol. 45, 466-472 (1999).
31. Kato T, Knopman D, Liu H: Dissociation of regional activation in mild AD during visual encoding: a functional MRI study. Neurology 57, 812-816 (2001).
32. Machulda MM, Ward HA, Borowski B et al.: Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients. Neurology 61, 500-506 (2003).
33. Grön G, Riepe MW. Neural basis for the cognitive continuum in episodic memory from health to Alzheimer disease. Am. J. Geriatr. Psychiatry 12, 648-652 (2004).
34. Dickerson BC, Salat DH, Greve DN et al.: Increased hippocampal activation in mild cognitive impairment compared with normal aging and AD. Neurology 65, 404-411 (2005).
35. Golby A, Silverberg G, Race E et al.: Memory encoding in Alzheimer's disease: an fMRI study of explicit and implicit memory. Brain 128, 773-787 (2005).
36. Remy F, Mirrashed F, Campbell B, Richter W: Verbal episodic memory impairment in Alzheimer's disease: a combined structural and functional MRI study. Neuroimage 25, 253-266 (2005).
37. Celone KA, Calhoun VD, Dickerson BC et al.: Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis. J. Neurosci. 26, 10222-10231 (2006).
38. Hämäläinen A, Pihlajamäki M, Tanila H et al.: Increased fMRI responses during encoding in mild cognitive impairment. Neurobiol, Aging 28, 1889-1903 (2007).
39. Johnson SC, Baxter LC, Susskind-Wilder L, et al.: Hippocampal adaptation to face repetition in healthy elderly and mild cognitive impairment. Neuropsychologia 42, 980-989 (2004).
40. Pihlajamäki M, Depeau K, Blacker D, Sperling RA: Impaired medial temporal repetition suppression is related to failure of parietal deactivation in Alzheimer disease. Am. J. Geriatr. Psychiatry 16(4), 283-292 (2008).
41. Gonsalves BD, Kahn I, Curran T, Norman KA, Wagner AD: Memory strength and repetition suppression: multimodal imaging of medial temporal cortical contributions to recognition. Neuron 47, 751-761 (2005).
42. Mesulam MM: From sensation to cognition. Brain 121, 1013-1052 (1998).
43. Grady CL, McIntosh AR, Beig S et al.: Evidence from functional neuroimaging of a compensatory prefrontal network in Alzheimer's disease. J. Neurosci. 23, 986-993 (2003).
44. Buckner RL: Memory and executive function in aging and AD: multiple factors that cause decline and reserve factors that compensate. Neuron 44, 195-208 (2004).
45. Gould RL, Brown RG, Owen AM et al.: Functional neuroanatomy of successful paired associate learning in Alzheimer's disease. Am. J. Psychiatry 162, 2049-2060 (2005).
46. Gould RL, Arroyo B, Brown RG et al.: Brain mechanisms of successful compensation during learning in Alzheimer disease. Neurology 67, 1011-1017 (2006).
47. Petersen RC, Doody R, Kurz A et al.: Current concepts in mild cognitive impairment. Arch. Neurol. 58, 1985-1992 (2001).
48. Petersen RC: Mild cognitive impairment: current research and clinical implications. Semin. Neurol. 27, 22-31 (2007).
49. Dickerson BC, Salat DH, Bates JF et al.: Medial temporal lobe function and structure in mild cognitive impairment. Ann. Neurol. 56, 27-35 (2004).
50. Kircher TT, Weis S, Freymann K et al.: Hippocampal activation in patients with mild cognitive impairment is necessary for successful memory encoding. J. Neurol. Neurosurg. Psychiatry 78, 812-818 (2007).
51. Johnson SC, Schmitz TW, Moritz CH et al.: Activation of brain regions vulnerable to Alzheimer's disease: the effect of mild cognitive impairment. Neurobiol, Aging 27, 1604-1612 (2006).
52. Petrella JR, Krishnan S, Slavin MJ et al.: Mild cognitive impairment: evaluation with 4-T functional MR imaging. Radiology 240, 177-186 (2006).
53. Rand-Giovannetti E, Chua EF, Driscoll AE et al.: Hippocampal and neocortical activation during repetitive encoding in older persons. Neurobiol. Aging 27, 173-182 (2006).
54. Miller SL, Celone K, Depeau K et al.: Age-related memory impairment associated with loss of parietal deactivation but preserved hippocampal activation. Proc. Natl Acad. Sci. USA 105, 2181-2186 (2008).
55. Hashimoto M, Masliah E: Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies. Neurochem. Res. 28, 1743-1756 (2003).
56. Stern EA, Bacskai BJ, Hickey GA et al.: Cortical synaptic integration in vivo is disrupted by amyloid-β plaques. J. Neurosci. 24, 4535-4540 (2004).
57. DeKosky ST, Ikonornovic MD, Styren SD et al.: Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann. Neurol. 51, 145-155 (2002).
58. Mondadori CR, Buchmann A, Mustovic H et al.: Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years. Brain 129, 2908-2922 (2006).
59. Minoshima S, Giordani B, Berent S et al.: Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann. Neurol. 42, 85-94 (1997).
60. Buckner RL, Snyder AZ, Sanders AL, Raichle ME, Morris JC: Functional brain imaging of young, nondemented, and demented older adults. J. Cogn. Neurosci. 12, 24-34 (2000).
61. D'Esposito M, Deouell LY, Gazzaley A: Alterations in the BOLD fMRI signal with ageing and disease: a challenge for neuroimaging. Nat. Rev. Neurosci. 4, 863-872 (2003).
62. Iadecola C: Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev. Neurosci. 5, 347-360 (2004).
63. Johnson NA, Jahng GH, Weiner MW et al.: Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology 234, 851-859 (2005).
64. Heun R, Freymann K, Erb M et al.: Mild cognitive impairment (MCI) and actual retrieval performance affect cerebral activation in the elderly. Neurobiol. Aging 28, 404-413 (2007).
65. Ries ML, Schmitz TW, Kawahara TN et al.: Task-dependent posterior cingulate activation in mild cognitive impairment. Neuroimage 29, 485-492 (2006).
66. Ries ML, Jabbar BM, Schmitz TW et al.: Anosognosia in mild cognitive impairment: relationship to activation of cortical midline structures involved in self-appraisal. J. Int. Neuropsychol. Soc. 13, 450-461 (2007).
67. Saykin AJ, Flashman LA, Frutiger SA et al.: Neuroanatomic substrates of semantic memory impairment in Alzheimer's disease: patterns of functional MRI activation. J. Int. Neuropsychol. Soc. 5, 377-392 (1999).
68. Grossman M, Koenig P, Glosser G et al.: Neural basis for semantic memory difficulty in Alzheimer's disease: an fMRI study. Brain 126, 292-311 (2003).
69. Vandenbulcke M, Peeters R, Dupont P, Van Hecke P, Vandenberghe R: Word reading and posterior temporal dysfunction in amnestic mild cognitive impairment. Cereb. Cortex 17, 542-551 (2007).
70. Dannhauser TM, Walker Z, Stevens T et al.: The functional anatomy of divided attention in amnestic mild cognitive impairment. Brain 128, 1418-1427 (2005).
71. Bokde AL, Lopez-Bayo P, Meindl T et al.: Functional connectivity of the fusiform gyrus during a face-matching task in subjects with mild cognitive impairment. Brain 129, 1113-1124 (2006).
72. Teipel SJ, Bokde AL, Born C et al.: Morphological substrate of face matching in healthy ageing and mild cognitive impairment: a combined MRI-fMRI study. Brain 130, 1745-1758 (2007).
73. Lustig C, Snyder AZ, Bhakta M et al.: Functional deactivations: change with age and dementia of the Alzheimer type. Proc. Natl Acad. Sci. USA 100, 14504-14509 (2003).
74. Greicius MD, Srivastava G, Reiss AL, Menon V: Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc. Natl Acad. Sci. USA 101, 4637-4642 (2004).
75. Rombouts SA, Barkhof F, Goekoop R, Stam CJ, Scheltens P: Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: an fMRI study. Hum. Brain Mapp. 26, 231-239 (2005).
76. Wang L, Zang Y, He Y et al.: Changes in hippocampal connectivity in the early stages of Alzheimer's disease: evidence from resting state fMRI. Neuroimage 31, 496-504 (2006).
77. Wang K, Liang M, Wang L et al.: Altered functional connectivity in early Alzheimer's disease: a resting-state fMRI study. Hum. Brain Mapp. 28, 967-978 (2007).
78. He Y, Wang L, Zang Y et al.: Regional coherence changes in the early stages of Alzheimer's disease: a combined structural and resting-state functional MRI study. Neuroimage 35, 488-500 (2007).
79. Petrella JR, Wang L, Krishnan S et al.: Cortical deactivation in mild cognitive impairment: high-field-strength functional MR imaging. Radiology 245, 224-235 (2007).
80. Sorg C, Riedl V, Muhlau M et al.: Selective changes of resting-state networks in individuals at risk for Alzheimer's disease, Proc. Natl Acad. Sci. USA 104, 18760-18765 (2007).
81. Buckner RL, Snyder AZ, Shannon BJ et al.: Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J. Neurosci. 25, 7709-7717 (2005).
82. 11C]PIB in a nondemented population: potential antecedent marker ofAlzheimer disease. Neurology 67, 446-452 (2006).
83. Forsberg A, Engler H, Almkvist O et al.: PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol. Aging (2007) (Epub ahead of print).
84. Nestor PJ, Fryer TD, Smielewski P, Hodges JR: Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment. Ann. Neurol. 54, 343-351 (2003).
85. Gould RL, Brown RG, Owen AM, Bullmore ET, Howard RJ: Task-induced deactivations during successful paired associates learning: an effect of age but not Alzheimer's disease. Neuroimage 31, 818-831 (2006).
86. Morcom, AM, Fletcher PC: Does the brain have a baseline? Why we should be resisting a rest. Neuroimage 37, 1073-1082 (2007).
87. Daselaar SM, Prince SE, Cabeza R: When less means more: deactivations during encoding that predict subsequent memory. Neuroimage 23, 921-927 (2004).
88. Grady CL, Springer MV, Hongwanishkul D, McIntosh AR, Winocur G: Age-related changes in brain activity across the adult lifespan. J. Cogn. Neurosci. 18, 227-241 (2006).
89. Small GW, Mazziotta JC, Collins MT et al.: Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA 273, 942-947 (1995).
90. Reiman EM, Caselh RJ, Yon LS et al.: Preclinical evidence of Alzheimer's disease in persons homozygous for the ε4 allele for apolipoprotein E. N. Engl, J. Med. 334, 752-758 (1996).
91. Bookheimer SY, Strojwas MH, Cohen MS et al.: Patterns of brain activation in people at risk for Alzheimer's disease. N. Engl. J. Med. 343, 450-456 (2000).
92. Burggren AC, Small GW, Sabb FW, Bookheimer SY: Specificity of brain activation patterns in people at genetic risk for Alzheimer disease. Am. J. Geriatr. Psychiatry 10, 44-51 (2002).
93. Smith CD, Andersen AH, Krystio RJ et al.: Women at risk for AD show increased parietal activation during a fluency task. Neurology 58, 1197-1202 (2002).
94. Bondi MW, Houston WS, Eyler IT, Brown GG: fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology 64, 501-508 (2005).
95. Fleisher AS, Houston WS, Eyler IT et al.: Identification of Alzheimer disease risk by functional magnetic resonance imaging. Arch. Neurol. 62, 1881-1888 (2005).
96. Wishart HA, Saykin AJ, Rabin LA et al.: Increased brain activation during working memory in cognitively intact adults with the APOE ε4 allele, Am. J. Psychiatry 163, 1603-1610 (2006).
97. Han SD, Houston WS, Jak AJ et al.: Verbal pired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response. Neurobiol. Aging 28, 238-247 (2007).
98. Smith CD, Andersen AH, Kryscio RJ et al.: Altered brain activation in cognitively intact individuals at high risk for Alzheimer's disease. Neurology 53, 1391-1396 (1999).
99. Lind J, Persson J, Ingvar M et al.: Reduced functional brain activity response in cognitively intact apolipoprotein E ε4 carriers. Brain 129, 1240-1248 (2006).
100. Trivedi MA, Schmitz TW, Ries ML et al.: Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk ofAlzheimer's disease: a cross-sectional study. BMC Med. 4, 1 (2006).
101. Borghesani PR, Johnson LC, Shelton AL et al.: Altered medial temporal lobe responses during visuospadal encoding in healthy APOE°4 carriers. Neurobiol. Aging (2007) (Epub ahead of print).
102. Bassett SS, Yousem DM, Cristinzio C et al.: Familial risk for Alzheimer's disease alters lMRI activation patterns. Brain 129, 1229-1239 (2006).
103. Johnson SC, Schmitz TW, Trivedi MA et al.: The influence of Alzheimer disease family history and apolipoprotein E ε4 on mesial temporal lobe-activation. J. Neurosci. 26, 6069-6076 (2006).
104. Machielsen WC, Rombouts SA, Barkhof F, Scheltens P, Witter MP: fMRI of visual encoding: reproducibility of activation. Hum. Brain Mapp. 9, 156-164 (2000).
105. Sperling R, Greve D, Dale A et al.: Functional MRI detection of pharmacologically induced memory impairment. Proc. Natl Acad Sci. USA 99, 455-460 (2002).
106. Harrington GS, Tomaszewski Farias S, Buonocore MH, Yonelinas AP: The intersubject and intrasubject reproducibility of fMRI activation during three encoding tasks: implications for clinical applications. Neuroradiology 48, 495-505 (2006).
107. Diamond EL, Miller S, Dickerson BC et al.: Relationship of fMRI activation to clinical trial memory measures in Alzheimer disease. Neurology 69, 1331-1341 (2007).
108. Johnson SC, Saykin AJ, Flashman LA, McAllister TW, Sparling MB: Brain activation on fMRI and verbal memory ability: functional neuroanatomic correlates of CVLT performance. J. Int. Neuropsychol. Soc. 7, 55-62 (2001).
109. Bentley P, Driver J, Dolan RJ: Cholinesterase inhibition modulates visual and attentional brain responses in Alzheimer's disease and health. Brain 131(Pt 2), 409-424 (2008).
110. McShane R, Areosa, Sastre A, Minakaran N: Memantine for dementia. Cochrane Database Syst. Rev. 2, CD003154 (2006).
111. ll Saykin AJ, Wishart HA, Rabin LA et al.: Cholinergic enhancement of frontal lobe activity in mild cognitive impairment. Brain 127, 1574-1583 (2004).
112. Kircher TT, Erb M, Grodd W, Leube DT. Cortical activation during cholinesterase-inhibitor treatment in Alzheimer disease: preliminary findings from a pharmaco-fMRI study. Am. J. Geriatr. Psychiatry. 13, 1006-1013 (2005).
113. Goekoop R, Rombouts SA, Jonker C et al.: Challenging the cholinergic system in mild cognitive impairment: a pharmacological fMRI study. Neuroimage 23, 1450-1459 (2004).
114. Goekoop R, Scheltens P, Barkhof F, Rombouts SA: Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation - a pharmacological fMRI study. Brain 129, 141-157 (2006).
115. Grön G, Brandenburg I, Wunderlich AP, Riepe MW: Inhibition of hippocampal function in mild cognitive impairment: targeting the cholinergic hypothesis. Neurobiol. Aging 27, 78-87 (2006).
116. Shanks MF, McGeown WJ, Forbes-McKay KE et al.: Regional brain activity after prolonged cholinergic enhancement in early Alzheimer's disease. Magn. Reson. Imaging 25, 848-859 (2007).
117. Rombouts SA, Barkhof F, Van Meel CS, Scheltens P: Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 73, 665-671 (2002).